Oncology
 |
|
6 december 2019 19:00:05 |
| Blue light-triggered optogenetic system for treating uveal melanoma (Oncogene) |
|
Tweet |
| 190 viewsCategory: Oncology |
 A TGF-?-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis (Oncogene)Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
